R
RCE
RECCE PHARMACEUTICAL
0.60
0.02+3.45%Closed16:10 12/15 AEDT
OPEN/PREV CLOSE0.575/0.580
TODAY RANGE0.560-0.600
VOL347.02K
MARKET CAP173.51M
52 WEEK RANGE0.275-0.625
AVG VOL (3M)201.31K
% TURNOVER0.09%
TURNOVER202.57K
P/E (TTM)-6.6372
% RANGE6.90%
EPS(TTM)-0.0904
P/E(FORWARD)-8.1081
P/B-56.6038
BVPS-0.0106
DIVIDEND--
P/S22.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP99.00M
SHARES OUTSTANDING289.18M
NEXT EARNINGS02/26-03/02
FREE FLOAT164.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·12/02 00:00
corporate presentation
ASX·11/26 23:07
Hong Kong Patent Granted for RECCE Anti-Infectives
ASX·11/25 22:52
Positive Efficacy Data for Inhaled R327 in HAP/VAP Model
ASX·11/14 05:10
Passing of Dr Graham Melrose - Recce founder and inventor
ASX·11/11 00:00
Company Conference Presentation
ASX·11/05 03:11
Results of Meeting
ASX·11/04 22:01
AGM Presentation
ASX·10/31 06:23
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·10/14 07:24
Change of Director's Interest Notices
ASX·10/08 00:00
Update - Notification of buy-back - RCE
ASX·10/07 21:35
Notification of cessation of securities - RCE
ASX·10/03 01:56
Notice of Annual General Meeting/Proxy Form
ASX·09/24 23:52
Patient Dosing Underway in Ph 3 Indonesia DFI Trial
ASX·09/15 00:00
2025 Annual General Meeting
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others